{
  "Figure": "nihms848554_page16_414.jpg",
  "Figure_title": "Figure 3. Duration of Treatment Each bar indicates the duration of treatment for the 25 “Phase 2-eligible” patients at the time  of data cutoff. Specific molecular alterations are shown next to each patient. Arrows indicate  patients who were ongoing on study; X denotes patients who discontinued the study (all due  to disease progression); black diamonds represent time of first response; black bars represent  three patients who experienced disease progression but remained on study due to clinical  benefit. "
}